SCHEMBL28940698

SCHEMBL28940698

CC(=O)c1cccc(-n2cc(-c3ccccc3)nn2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 3/20 0.59
▸ NFE2L2 Q16236 3/20 0.59
▸ STIM1 Q13586 5/20 0.56
▸ ORAI1 Q96D31 5/20 0.56
▸ OGT O15294 1/20 0.55
▸ HDAC3 O15379 3/20 0.55
▸ HDAC1 Q13547 2/20 0.55
▸ HDAC2 Q92769 2/20 0.55
▸ HDAC10 Q969S8 2/20 0.55
▸ HDAC8 Q9BY41 2/20 0.55
▸ HDAC6 Q9UBN7 2/20 0.55
▸ HSD17B1 P14061 1/20 0.53
▸ HSD17B2 P37059 1/20 0.53
▸ FLT3 P36888 1/20 0.51
▸ GSK3B P49841 1/20 0.51
▸ PTGS1 P23219 1/20 0.51
▸ PTGS2 P35354 1/20 0.51
▸ LDHA P00338 2/20 0.51
▸ ABCB1 P08183 1/20 0.50
▸ ABCG2 Q9UNQ0 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29626830 1.00 KEAP1 (0.59) KEAP1NFE2L2STIM1ORAI1OGT
SCHEMBL26628305 0.86 KEAP1 (0.69) KEAP1NFE2L2STIM1ORAI1OGT
SCHEMBL29946136 0.86 KEAP1 (0.69) KEAP1NFE2L2STIM1ORAI1OGT
SCHEMBL1427395 0.82 STIM1 (0.66) KEAP1NFE2L2STIM1ORAI1HSD17B1
SCHEMBL30932256 0.80 P2RY14 (0.53) KEAP1NFE2L2STIM1ORAI1OGT
SCHEMBL29946256 0.79 STIM1 (0.63) KEAP1NFE2L2STIM1ORAI1HSD17B1
SCHEMBL1429925 0.79 STIM1 (0.64) KEAP1NFE2L2STIM1ORAI1HSD17B1
SCHEMBL1430338 0.79 STIM1 (0.63) KEAP1NFE2L2STIM1ORAI1HSD17B1
SCHEMBL2711661 0.79 STIM1 (0.67) KEAP1NFE2L2STIM1ORAI1HSD17B1
SCHEMBL1429953 0.79 STIM1 (0.62) KEAP1NFE2L2STIM1ORAI1HSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114450271-A Ureas, amino and substituted heteroaryl compounds for Cbl-b inhibition 纽力克斯治疗公司 2022-05-06 — — CN disclosed
Send feedback